Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium.
about
Explaining the geographical variation of HIV among injection drug users in the United StatesSyringe possession arrests are associated with receptive syringe sharing in two Mexico-US border citiesSex-specific determinants of HIV infection among injection drug users in MontrealPersistence of low drug treatment coverage for injection drug users in large US metropolitan areasCorrelates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, Maryland.Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia.Sensitivity analysis using elicited expert information for inference with coarsened data: illustration of censored discrete event times in the AIDS Link to Intravenous Experience (ALIVE) Study.HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis.HIV seroprevalence in a sample of Tanzanian intravenous drug usersCorrelates of seeking injection assistance among injection drug users in Tijuana, Mexico.The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.HIV prevention with drug-using populations--current status and future prospects: introduction and overview.Drug abuse treatment as AIDS prevention.Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not doneSocial networks, risk-potential networks, health, and disease.[Injecting without getting infected: injectors' strategies to prevent HIV and HCV.]Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6HIV prevention among injection drug users: the need for integrated models.Continued spread of HIV among injecting drug users in southern Sichuan Province, China.Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop.Relationship characteristics associated with anal sex among female drug users.Neighborhood differences in patterns of syringe access, use, and discard among injection drug users: implications for HIV outreach and prevention education.Preliminary estimates of human immunodeficiency virus prevalence and incidence among cocaine abusers of Porto Alegre, Brazil.Incidence of HIV among injection drug users entering drug treatment programs in four US cities.The social determinants of emergency department and hospital use by injection drug users in Canada.Social contextual factors associated with entry into opiate agonist treatment among injection drug usersUpdate and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.Maintenance of endemicity in urban environments: a hypothesis linking risk, network structure and geography.Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: community-based surveys along major drug trafficking routes.Employment-based abstinence reinforcement promotes opiate and cocaine abstinence in out-of-treatment injection drug usersHIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusersHospital- versus community-based syringe exchange: a randomized controlled trialIncreasing quality of life and reducing HIV burden: the PATH+ intervention.Influence of different drugs on HIV risk in people who inject: systematic review and meta-analysis.The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil.Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users.Geographic proximity, policy and utilization of syringe exchange programmes.HIV risk behaviors in African-American drug injector networks: implications of injection-partner mixing and partnership characteristics.
P2860
Q24537299-87C84D9B-0C0B-430C-921D-85EFC49F3501Q24645135-2021FC0C-CCC3-48C9-83B2-A0EF0AE4987CQ28361596-93062C11-3FF7-4AD4-9CE2-D87759D026D1Q30496986-F17CD0BD-05AA-41F8-A2B6-ECE8EE975A98Q33231859-605E8827-D8AF-46EE-BB7A-F1E7ECFF8BD5Q33271708-B45E88E1-0E8B-457A-9820-7D6D2A84C7F7Q33379538-D1DC96FF-9BB8-433B-9281-E6260CAC8ED8Q33777428-E6D4ABA9-1D8C-4679-A4B4-9B3DE988C13BQ33822369-F81CA9D6-08F3-494A-BDC8-BA634B7C3646Q34026569-B4F89D62-A433-464C-9051-339B3737298CQ34135584-BDEBC461-AF7C-4942-A101-7412E22D6A46Q34163291-84F496E8-41B1-4983-BD23-5A6FF1521F63Q34196368-8A33EB5E-38F6-4CFF-871F-26882E4EC177Q34196421-3EB88D6C-A32F-4B0C-8604-4E33E82CE941Q34196480-99023BEA-6A51-46CD-9A3D-93933D2BB8ACQ34374727-57A834C6-B787-48FE-A622-9C9948844DC8Q35207698-C6497B01-6457-4AC8-93DF-3AA41FDC1BC4Q35529116-7F347D18-1737-4BBF-B0DA-DE0F6E143697Q35624688-FE10230C-DD28-4375-886B-092F3C7C3DF5Q35647060-5DE88D43-69F7-482A-874D-296A3F387119Q35688936-DB48ED89-B00A-48DB-99DA-4F515D63226FQ35755030-087FA930-6CE0-43F9-B9D0-F75F071D667FQ36272488-A970E9E9-18D5-446C-A5E2-3EE3DBFD5C6BQ36272978-90EDFF2F-E419-44C0-A068-E7832F54601EQ36273258-EC9497F9-1D82-4DEF-A93D-0A6A51FB34BBQ36274713-0C1FE80C-7771-43BB-BD13-2F23CE8FBE7CQ36376978-76C8523F-ABF0-4CAF-B101-2A3AEAC7119DQ36482454-212C0BB8-1B1D-4532-B9CA-851455931601Q36729409-88FCDB6C-95E5-42B6-8AED-D054612C0E2EQ36916069-064E6422-AE64-437F-94DC-6394DCAC2BE2Q36976784-F362D6C5-9F97-44F1-B14A-9D0BBEFE9FAFQ37069196-AEC2E353-B4DF-43B6-BC0B-C7F099A09931Q37298826-6B88ABBD-9383-4CC9-8502-9702AAC75828Q37368505-179DCC76-EE2D-48A1-8167-1737D625F93CQ37614167-80C20718-DBCF-413A-BFA4-E4A2530BF066Q38315761-97D0C8D6-B466-44D4-A84E-DCECDF58E624Q39707519-D5BE9829-A0DE-4B7E-A966-6CCE8DC7C5AEQ40480292-1D0DB125-E06E-4541-BE3E-656CD87539CDQ42612377-73B225CB-52A3-42A6-82C6-13512BFA8E83Q42681364-194BB6D7-8D7E-4BAD-9973-241BD5DF14DE
P2860
Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Risk factors for human immunod ...... onal AIDS Research Consortium.
@en
Risk factors for human immunod ...... onal AIDS Research Consortium.
@nl
type
label
Risk factors for human immunod ...... onal AIDS Research Consortium.
@en
Risk factors for human immunod ...... onal AIDS Research Consortium.
@nl
prefLabel
Risk factors for human immunod ...... onal AIDS Research Consortium.
@en
Risk factors for human immunod ...... onal AIDS Research Consortium.
@nl
P2093
P921
P1476
Risk factors for human immunod ...... onal AIDS Research Consortium.
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.AJE.A117726
P407
P577
1995-10-01T00:00:00Z